1Zimina EP, Bruckner-Tuderman L, Franzke C-W. Shedding of collagen XVII ectodomain depends on plasma membrane microenvironment. J Biol Chem 2005; 280:34019-34024.
2Hao M, Mukherjee S, Maxfield FR. Cholesterol depletion induces large scale domain segregation in living cell membranes. Proc Natl Acad Sci USA 2001; 98:13072-13077.
3Galbiati F, Razani B, Lisanti MP. Emerging themes in lipid rafts and caveolae. Cell 2001; 106:403-411.
4Edidin M. The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol Struct 2003; 32:257-283.
5Ceppi P, Colombo S, Francolini M, Raimondo F, Borgese N, Masserini M. Two domain-anchored protein variants, differing in transmembrane domain length and intraeellular sorting, interact differently with lipids. Proe Natl Acad Sei USA 2005;102:16269-16274.
6Yelamanchili SV, Reisinger C, Becher A, et al. The C-terminal transmembrane region of synaptobrevin binds synaptophysin from adult synaptic vesicles. Eur J Cell Biol 2005; 84:467-475.
7Greie JC, Heitkamp T, Altendorf K. The transmembrane domain of subunit b of the Escherichia coli F1F(O) ATP synthase is sufficient for H(+)-translocating activity together with subunits a and c. Eur J Biochem 2004; 271:3036-3042.
8Doedens JR, Mahimkar RM, Black RA. TACE/ADAM-17 enzymatic activity is increased in response to cellular stimulation. Biochem Biophys Res Commun 2003; 308:331-338.
9Black RA, Rauch CT, Kozlosky C J, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997; 385:729-733.
10Moss ML, Jin SL, Milla ME, et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997; 385:733-736.
3Balkwill F, Mantovani A. Inflammation and cancer: back to Vir- chow? Lancet, 2001, 357(9255) : 539-545.
4Movahedi K, Guilliams M, Van den Bossche J, et al. Identifica- tion of discrete tumor-induced myeloid-derived suppressor cell sub- populations with distinct T cell-suppressive activity. Blood, 2008, 111(8) : 4233-4244.
5Haile LA, Gamrekelashvili J, Manns MP, et al. CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice. J Immunol, 2010, 185(1) : 203-210.
6Ribechini E, Greifenberg V, Sandwick S, et al. Subsets, expan- sion and activation of myeloid-derived suppressor ceils. Medical Mierobiology and Immunology, 2010, 199(3) : 273-281.
7Ostrand-Rosenberg S, Sinha P. Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer. J Immunol, 2009, 182 (8) : 4499-4506.
8Tu S, Bhagat G, Cui G, et al. Overexpression of intedeukin- 1 beta induces gastric inflammation and cancer and mobilizes mye- loid-derived suppressor cells in mice. Cancer Cell, 2008, 14(5) : 408-419.
9Cheng L, Wang J, Li X, et al. Interleukin-6 Induces Gr-1 + CD11b + Myeloid Cells to Suppress CD8 + T Cell-Mediated Liver Injury in Mice. PLoS One, 2011, 6(3) : e17631.
10Sinha P, Clements VK, Fulton AM, et al. Prostaglandin E2 pro- motes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res, 2007, 67(9) : 4507-4513.
